Latest Commercialization News

Premier1 Lithium has reported promising high-grade gold mineralisation from maiden drilling at its Yalgoo and Abbotts North projects in Western Australia, highlighting significant exploration upside across extensive greenstone belts.

EBR Systems has announced a fully underwritten A$55.9 million capital raise alongside a Security Purchase Plan to fund the commercial rollout of its FDA-approved WiSE CRT System, targeting a US$3.6 billion market opportunity in cardiac resynchronization therapy.

EBR Systems has raised A$55.9 million through a fully underwritten placement to fund the commercial rollout of its FDA-approved wireless cardiac pacing system, with plans for a limited market release in H2 2025 and expanded distribution in 2026.

Provaris Energy has partnered with Yinson to develop large-scale liquid CO2 storage tanks and shipping solutions, aiming to meet surging demand in the expanding carbon capture and storage market.

SKS Technologies has delivered a robust first half in 2025, showcasing strong revenue growth and a burgeoning project pipeline, underpinned by zero debt and strategic expansion in data centres and traditional electrical services.

Patriot Resources has agreed to acquire a 100% interest in the Sugarloaf Copper Deposit, a high-grade asset in Zambia’s Mumbwa District, positioning the company for near-term copper production aligned with regional processing infrastructure.

Omega Oil and Gas has confirmed an extensive oil and gas system in Queensland’s Taroom Trough through high-quality logging at its Canyon-2 well, with DFIT testing now underway to further evaluate reservoir potential.

HyTerra Limited has reported exceptional hydrogen and helium concentrations from its Sue Duroche 3 well in Kansas, marking a significant milestone in natural gas exploration and clean energy potential.

Atlantic Lithium has announced the discovery of spodumene pegmatite with high-grade lithium assays at its Agboville and Rubino licences in Côte d’Ivoire, marking a significant expansion beyond its flagship Ghana project.

Lincoln Minerals’ Kookaburra Graphite Project has delivered battery-grade graphite purity exceeding 99.95%, confirming its suitability for lithium-ion battery anodes through a safer, hydrofluoric acid-free process.

Argenica Therapeutics has expanded its intellectual property with a new US patent targeting surgically induced strokes, enhancing the commercial potential of its lead drug candidate ARG-007.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.